Stock ICUI ICU MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials ICU Medical, Inc.

Equities

ICUI

US44930G1076

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
94.84 USD +0.33% Intraday chart for ICU Medical, Inc. -0.97% -4.91%
Mar. 20 Transcript : ICU Medical, Inc. Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-20-2024 02:15 PM
Mar. 15 Icu Medical Inc/de Insider Sold Shares Worth $812,741, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 3,868 4,500 5,041 3,777 2,408 2,311 - -
Enterprise Value (EV) 1 3,868 4,500 4,522 3,777 2,408 3,640 3,460 3,236
P/E ratio 39.9 x 53.4 x 50.1 x -50.6 x -81.1 x -49.8 x 43.3 x 25.2 x
Yield - - - - - - - -
Capitalization / Revenue 3.06 x 3.54 x 3.83 x 1.66 x 1.07 x 1.01 x 0.97 x 0.97 x
EV / Revenue 3.06 x 3.54 x 3.44 x 1.66 x 1.07 x 1.6 x 1.46 x 1.36 x
EV / EBITDA 14.4 x 18.5 x 17.3 x 10.5 x 6.4 x 10.3 x 8.31 x 7.12 x
EV / FCF 840 x 34.4 x 22.7 x -24.8 x 29.3 x 18 x 14.3 x 9.76 x
FCF Yield 0.12% 2.91% 4.4% -4.04% 3.42% 5.56% 6.99% 10.2%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 20,673 20,981 21,239 23,982 24,140 24,365 - -
Reference price 2 187.1 214.5 237.3 157.5 99.74 94.84 94.84 94.84
Announcement Date 2/27/20 2/25/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 1,266 1,271 1,316 2,280 2,259 2,280 2,375 2,388
EBITDA 1 268 243 260.7 358.7 376.1 353 416.4 454.5
EBIT 1 107.4 98.16 123.2 268.4 285.6 256.2 313.6 -
Operating Margin 8.48% 7.72% 9.36% 11.77% 12.64% 11.24% 13.21% -
Earnings before Tax (EBT) 1 114.7 97.49 123.2 -114.4 -78.3 -98.76 41.73 117.9
Net income 1 101 86.87 103.1 -74.29 -29.66 -46.29 54.17 90.8
Net margin 7.98% 6.83% 7.84% -3.26% -1.31% -2.03% 2.28% 3.8%
EPS 2 4.690 4.020 4.740 -3.110 -1.230 -1.903 2.190 3.770
Free Cash Flow 1 4.606 130.7 199 -152.4 82.31 202.2 242 331.5
FCF margin 0.36% 10.29% 15.12% -6.69% 3.64% 8.87% 10.19% 13.88%
FCF Conversion (EBITDA) 1.72% 53.8% 76.33% - 21.88% 57.28% 58.12% 72.94%
FCF Conversion (Net income) 4.56% 150.51% 192.95% - - - 446.76% 365.1%
Dividend per Share - - - - - - - -
Announcement Date 2/27/20 2/25/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 336.1 340.5 543.1 561 597.9 578 568.6 549.3 553.3 587.9 554 557.9 572.3 595.6 577.6
EBITDA 1 71.88 64.16 84.94 84.74 92.58 96.39 102 98.05 89.81 86.27 75 82.35 92.98 100.3 93.45
EBIT 1 38.38 23.82 63.08 61.16 72.59 71.58 78.8 75.16 69.12 62.5 51.3 58.93 69.5 76.7 67.4
Operating Margin 11.42% 7% 11.61% 10.9% 12.14% 12.38% 13.86% 13.68% 12.49% 10.63% 9.26% 10.56% 12.14% 12.88% 11.67%
Earnings before Tax (EBT) 37.92 23.34 -54.8 -16.85 -21.31 -21.45 - - - - - - - - -
Net income 1 31.08 19.92 -38.07 -7.474 -13.21 -15.54 -9.812 -9.934 7.238 -17.15 -16.98 -11.74 -4.14 1.455 -17.53
Net margin 9.25% 5.85% -7.01% -1.33% -2.21% -2.69% -1.73% -1.81% 1.31% -2.92% -3.07% -2.1% -0.72% 0.24% -3.03%
EPS 2 1.430 0.9100 -1.610 -0.3100 -0.5500 -0.6500 -0.4100 -0.4100 0.3000 -0.7100 -0.6950 -0.4800 -0.1700 0.0600 -0.7100
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 11/3/21 2/24/22 5/9/22 8/8/22 11/7/22 2/27/23 5/8/23 8/7/23 11/6/23 2/27/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - 1,329 1,149 926
Net Cash position 1 - - 519 - - - - -
Leverage (Debt/EBITDA) - - - - - 3.766 x 2.759 x 2.036 x
Free Cash Flow 1 4.61 131 199 -152 82.3 202 242 332
ROE (net income / shareholders' equity) 7.65% 6.03% 10.3% 8.49% -1.41% 0.85% 4.75% 4.2%
ROA (Net income/ Total Assets) 6.16% 5.03% 8.83% 4.92% -0.67% 1.4% 3.25% 2.1%
Assets 1 1,639 1,728 1,168 -1,510 4,447 -3,306 1,667 4,324
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 - - 12.30 -2.600 6.900 12.30 15.10 19.00
Capex 1 97.3 92 68.5 90.3 83.9 95.5 92.4 104
Capex / Sales 7.69% 7.24% 5.21% 3.96% 3.71% 4.19% 3.89% 4.33%
Announcement Date 2/27/20 2/25/21 2/24/22 2/27/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for ICU Medical, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
94.84 USD
Average target price
142.2 USD
Spread / Average Target
+49.99%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ICU MEDICAL, INC. Stock ICU Medical, Inc.
-4.91% 2.31B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.31% 187B
MEDTRONIC PLC Stock Medtronic plc
-3.20% 106B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.04% 66.9B
DEXCOM, INC. Stock DexCom, Inc.
+0.20% 49.45B
CENCORA, INC. Stock Cencora, Inc.
+17.29% 48B
HOYA CORPORATION Stock Hoya Corporation
+4.06% 40.84B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+2.36% 26.25B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+2.07% 26.48B
TERUMO CORPORATION Stock Terumo Corporation
+12.96% 24.62B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ICUI Stock
  4. Financials ICU Medical, Inc.